Shypd.aiThe largest open index of AI tools
DeepCure is a Wellness & Lifestyle tool that harnesses advanced AI and physics-based tools to discover novel small molecules for challenging targets. It focuses on reimagining small molecule therapies for immune diseases.
Trending
About
DeepCure is a Boston-based therapeutics company at the forefront of drug discovery, leveraging advanced AI, physics-based tools, and automation to identify novel small molecules. Their primary focus is on developing therapies for challenging targets, particularly within immune and inflammatory diseases. The company has a lead asset, DC-15442, an oral STAT6 inhibitor, currently in IND-enabling studies, demonstrating 100% in vivo inhibition of pSTAT6 and comparable efficacy to dupilumab. DeepCure also announced DC-9476 as a development candidate for multiple autoimmune diseases, including rheumatoid arthritis. They collaborate with world-class researchers, such as those at the Leeds Institute of Rheumatic and Musculoskeletal Medicine, to advance their pipeline and address intractable targets.
Capabilities
Pricing & Plans
Likely Not Free
Not publicly disclosed. Check deepcure.com for current pricing.
FAQs
Trending
